PHMMF (Pharma Mar) Tax Rate %: 4.06% (As of Mar. 2026)


PHMMF Pharma Mar SA PHMMF
82 GF Score
Price $90.90
GF Value $89.82
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Pharma Mar Tax Rate %?

Pharma Mar PHMMF -3.64% 82 Tax Rate % is 4.06% as of Mar. 2026. GuruFocus rates PHMMF with a GF Score™ of 82/100 and a GF Value™ of $89.82 (Fairly Valued). The stock has 3 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Pharma Mar's Tax Expense for the three months ended in Mar. 2026 was $0.1 Mil. Pharma Mar's Pre-Tax Income for the three months ended in Mar. 2026 was $1.8 Mil. Therefore, Pharma Mar's Tax Rate % for the quarter that ended in Mar. 2026 was 4.06%.

Pharma Mar Tax Rate % Related Terms

Pharma Mar Tax Rate % Historical Data

* Premium members only.

The historical data trend for Pharma Mar's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Tax Rate % Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.39 -12.71 131.38 -117.98 -25.71

Pharma Mar Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.16 -0.08 -0.59 -38.21 4.06
PHMMF
82GF Score
Pharma Mar SA PHMMF
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Pharma Mar's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=-17.957/69.849
=-25.71 %

Pharma Mar's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2026 )/Pre-Tax Income (Q: Mar. 2026 )
=0.075/1.847
=4.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 4.06% mean?
Pharma Mar (PHMMF) has a Tax Rate % of 4.06% as of Mar. 2026.
Is Pharma Mar's Tax Rate % too high?
Pharma Mar's current Tax Rate % is 4.06%. Overall, Pharma Mar has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's Tax Rate % compare to VRTX and REGN?
Pharma Mar's Tax Rate % of 4.06% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Pharma Mar's current Tax Rate % is 4.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Based on GuruFocus' analysis, Pharma Mar (PHMMF) is currently considered Fairly Valued. The stock's GF Value™ is $89.82, compared to a current price of $90.90 — trading 1.2% above its estimated fair value. The current Tax Rate % is 4.06%. Pharma Mar's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Pharma Mar (PHMMF), the current Tax Rate % is 4.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (PHMMF) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be overvalued. The current stock price of $90.90 is trading 1.2% above its estimated GF Value™ of $89.82. GuruFocus considers Pharma Mar to be Fairly Valued.

Key valuation signals for PHMMF:

  • Tax Rate %: 4.06%
  • GF Value™: $89.82 vs. price of $90.90 (1.2% above fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the PHMMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
82GF Score

Get the complete analysis for PHMMF

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.90
Price
$89.82
GF Value